Skip to main content
. 2016 Jun 28;6:157. doi: 10.3389/fonc.2016.00157

Table 2.

Distributions of age and PSA at diagnosis for diagnosed men and cancer deaths.

Age at diagnosis
Overall 50–59 60–69 70–79 80–89
Number of men diagnosed with prostate cancer vs. PSA at diagnosis

PSA (ng/mL)
0–2.9 70,836 8,761 19,112 28,881 14,082
3–4.9 40,912 7,292 15,039 14,200 4,381
5–9.9 67,512 10,729 24,432 25,049 7,302
10–19.9 27,323 3,333 7,419 10,984 5,587
20–49.9 13,217 1,385 2,884 5,094 3,854
50–99.9 4,434 405 840 1,676 1,513
≥100 5,847 481 1,137 2,167 2,062
Total 230,081 32,386 70,863 88,051 38,781

Number of men died of prostate cancer (% of diagnosed in category)

PSA (ng/mL)
0–2.9 4,467 (6) 171 (2) 629 (3) 1,980 (7) 1,687 (12)
3–4.9 2,203 (5) 112 (2) 414 (3) 1,023 (7) 654 (15)
5–9.9 3,301 (6) 263 (2) 855 (3) 2,043 (8) 1,140 (16)
10–19.9 3,749 (14) 181 (5) 618 (8) 1,710 (16) 1,240 (22)
20–49.9 3,553 (27) 196 (14) 545 (19) 1,490 (29) 1,322 (34)
50–99.9 1,933 (44) 128 (32) 306 (36) 805 (48) 694 (46)
≥100 3,936 (67) 320 (67) 724 (64) 1,502 (69) 1,390 (67)
Total 24,142 (10) 1,371 (4) 4,091 (6) 10,553 (12) 8,127 (21)